IEIH
iShares Evolved US Innvtv Hlthcare ETF
S&P Total Market TR USD
NAV as of
4 Week: 30.75 - 34.51
52 Week: 30.75 - 37.61
Latest Closing Price
31.87
Premium / Discount
0.09
Expense Ratio
0.18%
Investment Objective
The investment seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -10.12 | 1.27 | -7.94 |
| 1 Day | 1.82 | 0.00 | 0.00 |
| 1 Week | 0.35 | 5.16 | 0.07 |
| 1 Month | -9.48 | 7.60 | -1.25 |
| 3 Months | -2.88 | 10.71 | -0.27 |
| 6 Months | -8.89 | 13.01 | -0.68 |
| 1 Year | -2.32 | 16.26 | -0.14 |
| 2 Years | 9.22 | 24.94 | 0.37 |
| 3 Years | 31.69 | 35.48 | 0.89 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 22.1095 | 19.1410 | 12.3477 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 67.0000 | 58.0000 | 40.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 23/03/2022 | 29/03/2022 | 0.1488 |
| 12/12/2021 | 16/12/2021 | 0.0982 |
| 23/09/2021 | 29/09/2021 | 0.1246 |
| 09/06/2021 | 15/06/2021 | 0.0865 |
| 24/03/2021 | 30/03/2021 | 0.1064 |
| 13/12/2020 | 17/12/2020 | 0.0993 |
| 24/03/2020 | 30/03/2020 | 0.1039 |
| 15/12/2019 | 19/12/2019 | 0.0993 |
| 19/03/2019 | 25/03/2019 | 0.1010 |
| 25/09/2018 | 01/10/2018 | 0.0855 |
Portfolio Data
Total Number of Holdings: 273
Number of Bond Holdings: 0
Number of Equity Holdings: 271
Total Market Value: 34,558,034
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 8.5460 | 15,249 | 0 | 2,109,852 |
| 2 | Merck & Co Inc | 6.0239 | 19,522 | 0 | 1,487,186 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 38.51 |
| Large | 31.55 |
| Medium | 15.61 |
| Small | 8.35 |
| Micro | 4.43 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
12.3599
Price/Book*
3.9256
Price/Sales*
2.3677
Price/Cash Flow*
10.6492
Dividend Yield*
1.7471
Growth Measures
Long-Term Earnings
8.5763
Historical Earnings
26.9232
Sales Growth
12.9767
Cash-Flow Growth
22.7418
Book-Value Growth
10.3841
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
